Federal Court Hearing List

(As published on the Federal Court and Federal Court of Appeal websites on Nov 28, 2022 at 00:00:00)


This week in IP

DateFile No. Type Name LocationLength
Nov 28, 2022A-78-22APPAgc V. Catalyst Pharmaceuticals Inc. Et Al (unknown)Toronto1 d
Nov 28, 2022T-841-21CMCRovi Guides, Inc. V. Videotron Ltd. (Patent)Toronto30 m
Nov 29, 2022T-1517-21MHudson's Bay Company Ulc V. Zellers Inc. Et Al. (Trade Mark)Toronto10 m
Nov 29, 2022T-2276-22CMCBoehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)Toronto30 m
Nov 29, 2022T-2318-22CMCBoehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*)Toronto30 m
Nov 29, 2022T-2307-22CMCAstrazeneca Canada Inc. Et Al V. Pharmascience Inc. (Patent - Dapagliflozin*)Toronto30 m
Nov 29, 2022T-1838-22CMCAmgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto30 m
Nov 29, 2022T-1750-22CMCActelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*)Toronto30 m
Nov 30, 2022T-1257-22CMCBell Media Ind Et Al. V. Marshall Macciacchera Et Al (Copyright)Ottawa1 h
Nov 30, 2022T-1645-16MArkipelago Architecture Inc. V. Enghouse Systems Limited Et Al (Copyright)Toronto2 h
Nov 30, 2022T-717-20CMCGold Line Telemanagement Inc. Et Al. V. Ereele Gmbh (Trade Mark)Montréal1 h
Nov 30, 2022T-451-20CMCKobold Corporation Et Al. V. Ncs Multistage Inc. (Patent)Toronto30 m
Dec 1, 2022T-1059-22CMCSeylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark)Vancouver30 m
Dec 1, 2022T-1493-22CMCAbo Taheri V. Denna Homes Group (unknown)Vancouver30 m
Dec 1, 2022T-165-21MSJ7294140 Canada Inc. Dba Zoomtoner V. Connexlogix Inc. Et Al. (Trade Mark)Montréal1.3 d
Dec 1, 2022T-1213-21MLundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*)Toronto1.5 h
Dec 1, 2022T-668-21MLundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*)Toronto1.5 h
Dec 1, 2022T-919-21CMCMaoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent)Ottawa1 h
Dec 1, 2022T-1269-22MArk Innovation Technology Inc. V. 2xm Creations Inc. Et Al. (Copyright)Vancouver2 h

Return to top.



Scheduled IP Trials

DateFile No.Name LocationLength
Nov 14, 2022T-557-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-559-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-560-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-561-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-572-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-573-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-577-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto20 d
Nov 14, 2022T-581-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto20 d
Dec 5, 2022T-1213-21Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*)Toronto10 d
Dec 5, 2022T-668-21Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*)Toronto10 d
Dec 13, 2022T-581-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-557-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-559-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-560-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-561-21Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-572-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-573-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto2 d
Dec 13, 2022T-577-21Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*)Toronto2 d
Jan 9, 2023T-1007-20Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. Et Al (Patent)Toronto14 d
Feb 13, 2023T-512-202660722 Ontario Inc. Et Al. V. Vanpak Limited Et Al. (unknown)Ottawa10 d
Feb 20, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto7 d
Feb 20, 2023T-374-21Vidã?otron Ltã?e Et Al C. Technologies Konek Inc. Et Al (Copyright)Montréal8 d
Feb 27, 2023T-788-21Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*)Toronto4 d
Mar 3, 2023T-343-20The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent)Toronto1 d
Mar 6, 2023T-788-21Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*)Toronto4 d
Mar 13, 2023T-788-21Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*)Toronto4 d
Mar 20, 2023T-703-20Kaira District Coop Milk Producers Union Ltd Et Al V Amul Canada Ltd Et Al (Trade Mark)Toronto5 d
Mar 23, 2023T-788-21Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*)Toronto2 d
Apr 11, 2023T-711-20Bell Canada V. Skychoice Communications Inc. (Trade Mark)Toronto8 d
Apr 17, 2023T-609-20Wanakome Inc. V. Eric Martin Et Al. (Trade Mark)Montréal10 d
Apr 17, 2023T-127-19Fromfroid S.a. C. 1048547 Ontario Inc. Et Al. (Patent)Montréal5 d
May 8, 2023T-1924-17Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright)Toronto10 d
Jun 5, 2023T-1168-21Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (PMNOC - Section 8 - Abiraterone*)Toronto10 d
Jun 5, 2023T-1966-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)To be determined (TrialJA)8 d
Jun 5, 2023T-379-21Molo Design, Ltd. V. Chanel Canada Ulc Et Al. (Patent)Montréal10 d
Jun 19, 2023T-1966-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)To be determined (TrialJA)2 d
Jun 19, 2023T-607-21Apotex Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*)Toronto10 d
Jun 26, 2023T-17-16Ducks Lane Ltd. Et Al V. Outforont Media Llc Et Al (Trade Mark)Toronto5 d
Jul 10, 2023T-1472-21Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)Toronto15 d
Jul 10, 2023T-1475-21Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*)Toronto15 d
Sep 11, 2023T-1962-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)To be determined (TrialJA)5 d
Sep 11, 2023T-1994-21Allergan, Inc. Et Al. V. Juno Pharmaceuticals Corp. (Patent - Bimatoprost*)Toronto10 d
Sep 21, 2023T-1962-21Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*)To be determined (TrialJA)2 d
Sep 25, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto2 d
Oct 3, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto4 d
Oct 3, 2023T-15-22Boehringer Ingleheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent - Linagliptin*)Toronto16 d
Oct 10, 2023T-1869-21Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*)Toronto4 d
Oct 16, 2023T-151-22Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*)To be determined (TrialJA)10 d
Oct 16, 2023T-653-21Apotex Inc. V. Servier Canada Inc. (Patent - Perindopril*)Toronto10 d
Oct 30, 2023T-192-22Novartis Pharmaceuticals Canada Inc. Et Al. V. Teva Canada Limited (Patent - Sacubitril*)Ottawa10 d
Nov 9, 2023T-151-22Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*)To be determined (TrialJA)2 d
Nov 20, 2023T-1386-21Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent)To be determined (TrialJA)12 d
Jan 8, 2024T-1004-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*)Toronto13 d
Jan 8, 2024T-1006-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*)Toronto13 d
Feb 5, 2024T-1004-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*)Toronto2 d
Feb 5, 2024T-1006-22Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*)Toronto2 d
Feb 12, 2024T-997-22Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*)Toronto7 d
Feb 29, 2024T-997-22Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*)Toronto2 d
Mar 4, 2024T-1484-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*)Toronto10 d
Mar 4, 2024T-1607-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*)Toronto10 d
Mar 11, 2024T-1187-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1188-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1175-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent)Toronto13 d
Mar 11, 2024T-1176-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1178-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 11, 2024T-1181-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto13 d
Mar 18, 2024T-1121-22Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1122-22Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1248-22Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 18, 2024T-1249-22Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*)Toronto5 d
Mar 25, 2024T-1484-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*)Toronto2 d
Mar 25, 2024T-1607-22Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*)Toronto2 d
Apr 4, 2024T-1187-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1188-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1175-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent)Toronto2 d
Apr 4, 2024T-1176-22Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1178-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 4, 2024T-1181-22Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*)Toronto2 d
Apr 8, 2024T-1555-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*)Toronto9 d
Apr 8, 2024T-1556-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*)Toronto9 d
Apr 29, 2024T-1556-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*)Toronto1 d
Apr 29, 2024T-1555-22Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*)Toronto1 d
Apr 29, 2024T-1337-22Merck Sharp & Dohme Llc Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*)Toronto3 d
May 3, 2024T-1337-22Merck Sharp & Dohme Llc Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*)Toronto1 d
May 6, 2024T-1563-22Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*)Toronto10 d
May 7, 2024T-1750-22Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*)Toronto9 d
May 24, 2024T-1750-22Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*)Toronto1 d
May 27, 2024T-1482-22Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*)To be determined (TrialJA)10 d
May 27, 2024T-1766-22Bayer Inc. Et Al V. Bgp Pharma Ulc D.b.a. Viatris Canada (Patent - Aflibercept*)To be determined (TrialJA)10 d
May 27, 2024T-1563-22Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*)Toronto2 d
May 27, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto12 d
Jun 14, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto6 d
Jul 2, 2024T-1838-22Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*)Toronto2 d
Nov 18, 2024T-1462-22Merck Sharp And Dohme Llc Et Al V. Pharmascience Inc. Et Al (Patent - Sitagliptin*)Toronto10 d
Dec 9, 2024T-1462-22Merck Sharp And Dohme Llc Et Al V. Pharmascience Inc. Et Al (Patent - Sitagliptin*)Toronto1 d

Return to top.



Scheduled Judicial Review Hearings

DateFile No.Name TypeLocationLength
Dec 14, 2022T-1867-21Janssen Inc. V. Attorney General Of Canada Et Al.S. 18.1 Application for Judicial ReviewToronto1 d
Feb 2, 2023T-1172-21Standard International Management Llc V. Asia Standard Management Services LTrade Mark - Appeal of a decision of the RegistrarToronto1 d
Feb 2, 2023T-424-22Empire Comfort Systems, Inc. V. Onward Multi-corp Inc.Trade Mark - Appeal of a decision of the RegistrarOttawa1 d
Feb 2, 2023T-423-22Empire Comfort Systems, Inc. V. Onward Multi-corp Inc.Trade Mark - Appeal of a decision of the RegistrarOttawa1 d
Apr 17, 2023T-1664-22Novartis Ag Et Al V. Biogen, Inc. Et AlTrade Mark InfringementToronto2 d

Return to top.



Scheduled IP Appeals

DateFile No.Name TypeLocationLength
Nov 28, 2022A-78-22Agc V. Catalyst Pharmaceuticals Inc. Et AlAppeal (S.27 - Final) - Statutory Appeal [from T-1047-21 - S. 18.1 Application for Judicial Review]Toronto1 d

* Medicinal ingredients are based on automated analysis and should not be relied upon.

Return to top.

Canadian Intellectual Property